Logo image of ATS

ATS CORP (ATS) Stock Fundamental Analysis

NYSE:ATS - New York Stock Exchange, Inc. - CA00217Y1043 - Common Stock - Currency: USD

25.55  -0.24 (-0.93%)

After market: 25.55 0 (0%)

Fundamental Rating

3

Overall ATS gets a fundamental rating of 3 out of 10. We evaluated ATS against 128 industry peers in the Machinery industry. While ATS is still in line with the averages on profitability rating, there are concerns on its financial health. ATS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ATS had positive earnings in the past year.
In the past year ATS has reported a negative cash flow from operations.
In the past 5 years ATS has always been profitable.
ATS had a positive operating cash flow in each of the past 5 years.
ATS Yearly Net Income VS EBIT VS OCF VS FCFATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

ATS has a worse Return On Assets (1.91%) than 60.16% of its industry peers.
The Return On Equity of ATS (5.09%) is comparable to the rest of the industry.
ATS has a Return On Invested Capital of 5.46%. This is comparable to the rest of the industry: ATS outperforms 41.41% of its industry peers.
ATS had an Average Return On Invested Capital over the past 3 years of 7.85%. This is below the industry average of 10.31%.
Industry RankSector Rank
ROA 1.91%
ROE 5.09%
ROIC 5.46%
ROA(3y)4.1%
ROA(5y)3.55%
ROE(3y)11.76%
ROE(5y)9.71%
ROIC(3y)7.85%
ROIC(5y)7.1%
ATS Yearly ROA, ROE, ROICATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ATS has a Profit Margin (3.25%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ATS has grown nicely.
The Operating Margin of ATS (8.98%) is comparable to the rest of the industry.
ATS's Operating Margin has improved in the last couple of years.
ATS has a Gross Margin of 29.64%. This is comparable to the rest of the industry: ATS outperforms 46.88% of its industry peers.
In the last couple of years the Gross Margin of ATS has grown nicely.
Industry RankSector Rank
OM 8.98%
PM (TTM) 3.25%
GM 29.64%
OM growth 3Y10.39%
OM growth 5Y3.89%
PM growth 3Y12.53%
PM growth 5Y2.52%
GM growth 3Y2.82%
GM growth 5Y1.64%
ATS Yearly Profit, Operating, Gross MarginsATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ATS is destroying value.
ATS has more shares outstanding than it did 1 year ago.
ATS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ATS has an improved debt to assets ratio.
ATS Yearly Shares OutstandingATS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ATS Yearly Total Debt VS Total AssetsATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 1.96 indicates that ATS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ATS (1.96) is worse than 67.19% of its industry peers.
A Debt/Equity ratio of 0.98 indicates that ATS is somewhat dependend on debt financing.
ATS's Debt to Equity ratio of 0.98 is on the low side compared to the rest of the industry. ATS is outperformed by 76.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.96
ROIC/WACC0.63
WACC8.67%
ATS Yearly LT Debt VS Equity VS FCFATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.92 indicates that ATS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.92, ATS perfoms like the industry average, outperforming 44.53% of the companies in the same industry.
ATS has a Quick Ratio of 1.58. This is a normal value and indicates that ATS is financially healthy and should not expect problems in meeting its short term obligations.
ATS has a better Quick ratio (1.58) than 67.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.58
ATS Yearly Current Assets VS Current LiabilitesATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

ATS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.30%.
The Earnings Per Share has been growing by 21.73% on average over the past years. This is a very strong growth
ATS shows a decrease in Revenue. In the last year, the revenue decreased by -7.46%.
The Revenue has been growing by 19.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-36.3%
EPS 3Y34.78%
EPS 5Y21.73%
EPS Q2Q%-50.77%
Revenue 1Y (TTM)-7.46%
Revenue growth 3Y28.48%
Revenue growth 5Y19.33%
Sales Q2Q%-13.3%

3.2 Future

The Earnings Per Share is expected to decrease by -1.99% on average over the next years.
Based on estimates for the next years, ATS will show a small growth in Revenue. The Revenue will grow by 2.91% on average per year.
EPS Next Y-44.6%
EPS Next 2Y-10.55%
EPS Next 3Y-1.99%
EPS Next 5YN/A
Revenue Next Year-10.73%
Revenue Next 2Y0.53%
Revenue Next 3Y2.91%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ATS Yearly Revenue VS EstimatesATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ATS Yearly EPS VS EstimatesATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.60, ATS is valued on the expensive side.
ATS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.82, ATS is valued a bit cheaper.
With a Price/Forward Earnings ratio of 16.90, ATS is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ATS is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, ATS is valued a bit cheaper.
Industry RankSector Rank
PE 20.6
Fwd PE 16.9
ATS Price Earnings VS Forward Price EarningsATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ATS is valued a bit cheaper than the industry average as 60.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.51
ATS Per share dataATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.95
EPS Next 2Y-10.55%
EPS Next 3Y-1.99%

0

5. Dividend

5.1 Amount

ATS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATS CORP

NYSE:ATS (5/23/2025, 9:14:24 PM)

After market: 25.55 0 (0%)

25.55

-0.24 (-0.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners94.54%
Inst Owner ChangeN/A
Ins Owners0.8%
Ins Owner ChangeN/A
Market Cap2.50B
Analysts76.67
Price Target36.14 (41.45%)
Short Float %4.5%
Short Ratio31.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.87%
Min EPS beat(2)-22.3%
Max EPS beat(2)-1.43%
EPS beat(4)1
Avg EPS beat(4)-2.88%
Min EPS beat(4)-22.3%
Max EPS beat(4)16.48%
EPS beat(8)3
Avg EPS beat(8)2.86%
EPS beat(12)5
Avg EPS beat(12)4.97%
EPS beat(16)9
Avg EPS beat(16)11.76%
Revenue beat(2)0
Avg Revenue beat(2)-3.12%
Min Revenue beat(2)-5.85%
Max Revenue beat(2)-0.4%
Revenue beat(4)1
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-5.85%
Max Revenue beat(4)8.66%
Revenue beat(8)5
Avg Revenue beat(8)2.01%
Revenue beat(12)7
Avg Revenue beat(12)1.76%
Revenue beat(16)11
Avg Revenue beat(16)2.85%
PT rev (1m)2.24%
PT rev (3m)3.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 20.6
Fwd PE 16.9
P/S 1.26
P/FCF N/A
P/OCF N/A
P/B 1.98
P/tB N/A
EV/EBITDA 12.51
EPS(TTM)1.24
EY4.85%
EPS(NY)1.51
Fwd EY5.92%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS20.25
BVpS12.91
TBVpS-2.73
PEG (NY)N/A
PEG (5Y)0.95
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 5.09%
ROCE 6.89%
ROIC 5.46%
ROICexc 5.89%
ROICexgc 16.29%
OM 8.98%
PM (TTM) 3.25%
GM 29.64%
FCFM N/A
ROA(3y)4.1%
ROA(5y)3.55%
ROE(3y)11.76%
ROE(5y)9.71%
ROIC(3y)7.85%
ROIC(5y)7.1%
ROICexc(3y)8.35%
ROICexc(5y)7.9%
ROICexgc(3y)29.75%
ROICexgc(5y)26.65%
ROCE(3y)9.91%
ROCE(5y)8.97%
ROICexcg growth 3Y6.21%
ROICexcg growth 5Y-6.28%
ROICexc growth 3Y10.14%
ROICexc growth 5Y0.41%
OM growth 3Y10.39%
OM growth 5Y3.89%
PM growth 3Y12.53%
PM growth 5Y2.52%
GM growth 3Y2.82%
GM growth 5Y1.64%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 4.3
Cap/Depr 49.76%
Cap/Sales 2.73%
Interest Coverage 3.23
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.58
Altman-Z 1.96
F-Score4
WACC8.67%
ROIC/WACC0.63
Cap/Depr(3y)57.61%
Cap/Depr(5y)59.33%
Cap/Sales(3y)2.82%
Cap/Sales(5y)2.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.3%
EPS 3Y34.78%
EPS 5Y21.73%
EPS Q2Q%-50.77%
EPS Next Y-44.6%
EPS Next 2Y-10.55%
EPS Next 3Y-1.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.46%
Revenue growth 3Y28.48%
Revenue growth 5Y19.33%
Sales Q2Q%-13.3%
Revenue Next Year-10.73%
Revenue Next 2Y0.53%
Revenue Next 3Y2.91%
Revenue Next 5YN/A
EBIT growth 1Y-22.14%
EBIT growth 3Y41.83%
EBIT growth 5Y23.97%
EBIT Next Year-6.48%
EBIT Next 3Y8.3%
EBIT Next 5YN/A
FCF growth 1Y-697.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.21%
OCF growth 3Y-51.77%
OCF growth 5Y-30.44%